ID: ALA3091609

Max Phase: Preclinical

Molecular Formula: C17H17NO6

Molecular Weight: 331.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1CCc1nc(C)c(O)c(C(=O)O)c1C(=O)O

Standard InChI:  InChI=1S/C17H17NO6/c1-9-15(19)14(17(22)23)13(16(20)21)11(18-9)8-7-10-5-3-4-6-12(10)24-2/h3-6,19H,7-8H2,1-2H3,(H,20,21)(H,22,23)

Standard InChI Key:  RONXHOZQKXTIQZ-UHFFFAOYSA-N

Associated Targets(Human)

P2X purinoceptor 7 5534 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P2X purinoceptor 3 1991 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2X purinoceptor 1 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.32Molecular Weight (Monoisotopic): 331.1056AlogP: 2.29#Rotatable Bonds: 6
Polar Surface Area: 116.95Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.78CX Basic pKa: 2.53CX LogP: 2.32CX LogD: -2.94
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.74Np Likeness Score: 0.03

References

1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC..  (2013)  Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators.,  70  [PMID:24246730] [10.1016/j.ejmech.2013.10.026]

Source